Skip to main content
Quest Diagnostics

Hepatitis C Virus Clearance Cascade — United States, 2013–2022

Hepatitis C virus clearance cascade — United States, 2013–2022

Authors: Wester C, Osinubi A, Kaufman HW, Symum H, Meyer 3rd WA, Huang X, Thompson WW

MMWR Morb Mortal Wkly Rep. 2023;72(26):716-720. doi: 10.15585/mmwr.mm7226a3

Specialties: Infectious disease

Related content

Publication
Hepatitis C Virus Testing During Pregnancy Following Universal Screening Recommendations
Publication
Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic
Publication
Relationship Between Hepatitis C Virus (HCV) IgG Index Values and Quantitative HCV RNA Results in HCV IgG-Reactive Serum Samples
Test FAQ
Donor Testing
On-Demand Webinar
HBV Webinar: From Screening to Functional Cure

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.